Origin Therapeutics Holdings, Inc. engages in the provision of investment services for psychedelic industry. It also plans to invest in opportunities involving, where legally permitted, the research, design, development, testing, production, distribution, and sale of psychedelics and services. The company was founded on December 9, 2020 and is headquartered in Vancouver, Canada.